Question 1

What is Ono Pharmaceutical (Japan) known for?

Accepted Answer

In research, Ono Pharmaceutical (Japan) stands highest in Life Sciences (#6,571 of 11,023 worldwide), Biochemistry, Genetics and Molecular Biology (#3,663 of 5,801 worldwide) and Health Sciences (#11,031 of 16,688 worldwide), over all time.

Question 2

How does Ono Pharmaceutical (Japan) rank in research?

Accepted Answer

Ono Pharmaceutical (Japan) ranks #18,634 of 22,385 institutions worldwide on research quality in 2022-now (#19,975 all time), and #592 of 924 in Japan.

Question 3

Who are the top researchers at Ono Pharmaceutical (Japan)?

Accepted Answer

Ranked on the quality score, Shinji Nakade, Tsumoru Miyamoto and Yoshikazu Takaoka lead among researchers whose main affiliation is Ono Pharmaceutical (Japan).

Question 4

What are the most cited papers from Ono Pharmaceutical (Japan)?

Accepted Answer

The most cited paper from Ono Pharmaceutical (Japan) is "Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial" (Ken Kato, Byoung Chul Cho, Masanobu Takahashi et al., 2019), with 1,262 citations. Next come "2APB, 2-Aminoethoxydiphenyl Borate, a Membrane-Penetrable Modulator of Ins(1,4,5)P3-Induced Ca2+ Release" (918) and "Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial" (808).

Question 5

Which research topics does Ono Pharmaceutical (Japan) publish most on?

Accepted Answer

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research and Nutrition and Health in Aging.

Question 6

Which keywords describe research at Ono Pharmaceutical (Japan)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Immunotherapy, Tumor Microenvironment, Lymphoma, Chemotherapy, Cancer Immunotherapy, Prognostic Factors and Rituximab.

Question 7

Which fields of science does Ono Pharmaceutical (Japan) work in?

Accepted Answer

In 2022-now, 50% of research at Ono Pharmaceutical (Japan) is in Health Sciences, 24% in Physical Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (14%), Chemistry (9%). It does 2.0× the world's share of Health Sciences.

Question 8

Is Ono Pharmaceutical (Japan)'s research output growing?

Accepted Answer

Output in 2022-2025 was 31% lower than in 2018-2021.